Aging populations and clearer U.S. drug pricing boost long-term pharma outlook. Leaders like Eli Lilly and Merck lead in ...

Success with a smart VF is less about the screens and more about how people interact with the data and each other.

Investing in biotechnology often feels like navigating a minefield. A single failed clinical trial can decimate a stock, ...

Leading clinicians, researchers & pharmaceutical innovators gathered to discuss the future of cancer treatment.

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...

By 2050, nearly half of the world’s population is predicted to have myopia. Despite this growing trend, eye health remains a ...

As more pharma companies launch DTC platforms, marketers will need to develop strategies that take patient experience and transparency into account.

With Most Favored Nation (MFN) and the emergence of the direct-to-consumer (DTC) model and potential tariffs, traditional roles of payers, pharmacy benefit managers, manufacturers, and 340B hospitals ...

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from the country, blaming insufficient government investment. Central to the ...

Fierce’s Rebecca Willumson sat down with Swoop President Scott Rines – live at Digital Pharma East – to discuss some of the most pressing issues in pharma marketing today. Rines kicks off by debunking ...

BW Pharma Awards 2025 recognizes India’s pharmaceutical innovators driving excellence, ethics, and transformation in global healthcare ...

Bridgebio Pharma (($BBIO)) has held its Q3 earnings call. Read on for the main highlights of the call. BridgeBio Pharma’s recent earnings call ...